Search the Newsreel

Should Osisko Metals’ Widening Net Losses (Q2 2026) Require Action From Osisko Metals (TSX:OM) Investors?

Kolibri Global Energy (TSX:KEI) Stock Climbs On Record Margins And Earnings

Kothari Products consolidated net profit declines 64.71% in the June 2026 quarter

Koninklijke Ahold Delhaize (ENXTAM:AD) Could Be 46% Below Fair Value As AI Gains Land

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Koninklijke Ahold Delhaize (ENXTAM:AD) is attracting fresh attention after its Delhaize banner rolled out SymphonyAI demand forecasting and replenishment tools across Belgium, reporting higher forecast …

Nomura Downgrades Korea Electric Power to Neutral From Buy, Adjusts Price Target to KRW40,000 From KRW61,000

Nomura has downgraded Korea Electric Power to "Neutral" from "Buy" and significantly reduced its price target from KRW61,000 to KRW40,000. This adjustment reflects a more cautious outlook on the company's prospects. The article also briefly mentions recent news about Korea Electric Power, including earnings …

Kohinoor Foods reports consolidated net profit of Rs 2.10 crore in the June 2026 quarter

Vivakor | 8-K: Current report

This document is an 8-K current report filed by Vivakor. The 8-K form is used by public companies to announce significant events that investors should know about. Without further content, the specific nature of this significant event is unknown.

Mako Mining Corp. Bottom Line Climbs In Q2

(RTTNews) - Mako Mining Corp. (MKO.V) revealed a profit for its second quarter that Increased, from last year The company's bottom line totaled $13.86 million, or $0.15 per share. This compares with $8.82 million, or $0.11 per share, last year. The company's revenue for …

Rekor targets adjusted EBITDA profitability in H2 2026 as GoSecure expands into audio

Earnings Call Insights: Rekor Systems (REKR) Q2 2026 MANAGEMENT VIEW * CEO Robert Berman framed Q2 as evidence that restructuring is flowing through results, saying, "Q2 shows the impact of the actions we said we were taking in the second half of '26. Revenue …

Insider Selling: Glaukos (NYSE:GKOS) COO Sells 60,000 Shares of Stock

Glaukos Corporation's COO, Joseph Gilliam, sold 60,000 shares of company stock for approximately $10.8 million, reducing his direct ownership by 45.25%. The sale occurred while Glaukos shares were trading near a 52-week high, and the company recently reported strong quarterly revenue and beat EPS …

Newtek (NEWT) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Executive Vice President and Chief Financial Officer - Frank DeMaria President, Chief Executive Officer, and Chairman - Barry R. Sloane Full Conference Call Transcript Operator: Good day and …

Glaukos COO Joseph Gilliam sells $10.7m in stock

Glaukos Corporation's COO, Joseph Gilliam, sold 60,000 shares of company stock for $10.7 million after exercising stock options. These sales occurred when the stock was near its 52-week high, and Gilliam now beneficially owns 72,588 shares. The transactions follow recent strong Q2 2026 financial …

Philips (ENXTAM:PHIA) Expands Open Monitoring Ecosystem And Launches Postpartum Support Tool

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Koninklijke Philips (ENXTAM:PHIA) announces new collaborations to expand its open monitoring ecosystem and connected …

Kornit Digital (KRNT) Stock Stalls As Recurring Revenue Rises But Losses Deepen

Kornit Digital's stock remained largely flat despite its Q2 2026 earnings report, which showed an 11% increase in revenue to US$55.3m and a significant 79% rise in annual recurring revenue (ARR) to US$33.8m. However, the company's net loss widened to US$11.2m, intensifying the debate …

Insider Selling: Korro Bio (NASDAQ:KRRO) Director Sells $29,916.28 in Stock

Korro Bio (NASDAQ:KRRO) director Jean Francois Formela sold 2,143 shares of the company's stock for $29,916.28 on August 11th, reducing his holdings by 1.45% to 145,937 shares. This sale is part of a pattern of recent insider selling by Formela, including significant transactions in …

Coca-Cola’s Raised Guidance And Margin Gains Might Change The Case For Investing In Coca-Cola (KO)

Coca-Cola recently posted a strong second quarter, with healthy global demand, improving margins, broad-based volume growth, and management raising full-year revenue and earnings guidance. This upgraded outlook, alongside ongoing market-share gains and disciplined cost control, has reinforced investor confidence in the company's ability to …

Form 8K Vivakor Inc For: 13 August By Investing.com

This article reports on Vivakor Inc.'s Form 8K filing for August 13. The company, trading under the symbol VIVK, experienced a slight dip in its stock performance. The content primarily serves as a notice of the filing and a brief update on the stock's …

OshKosh makes strategic investment in robotics company, United States. News story in Forkliftaction News

OshKosh Corporation has made a strategic investment in Boston-based AI, robotics, and industrial automation company, Nextera Robotics. The investment's value and the acquired stake were not disclosed, but OshKosh plans to accelerate the deployment of Nextera's technology within the construction sector. Nextera develops autonomous …

Korea Electric Power 2Q Net Profit Missed FactSet-Compiled Consensus

This article provides financial results for Korea Electric Power (KEP). The company reported a net profit for the second quarter that fell short of the consensus forecast compiled by FactSet. The specific financial figures and the extent of the miss would be detailed within …

Amkor Technology Inc (AMKR) Stock Up 3.9% but GF Value Says Over

Despite a 3.9% stock increase for Amkor Technology Inc (AMKR), GuruFocus's GF Value™ suggests the stock is overvalued by 63.0% at $57.75 compared to its intrinsic value of $35.44. The company has a GF Score™ of 79/100, indicating overall strong performance, but a low …

Kontoor Brands (KTB) Stock Jumps On Buyback Push Despite Revenue Slide

Kontoor Brands (KTB) stock saw a significant jump after reporting Q2 results, reinforcing its premium label status with higher profit guidance and a US$400m accelerated share repurchase plan. Despite an 11.2% revenue decline and a 22.8% net income decline year-over-year, investors were encouraged by …

Osisko Gold completes ~2.7 km of Cariboo underground development

Kochav Defense Acquisition Corp. Class A Ordinary Shares (NASDAQ: KCHV) Stock Price, News & Analysis

This article provides stock price, news, and analysis for Kochav Defense Acquisition Corp. Class A Ordinary Shares (NASDAQ: KCHV). It includes real-time stock data, fundamental metrics, and outlines available financial reports and research services provided by Kalkine, which are primarily sourced from EOD Historical …

Kochav Defense Acquisition Corp. Q2 2026: Net income $2.13M, EPS $0.06— 10-Q Summary

Washington Mutual Investors Fund, AWSHX, Refuses to Buy Certain Stocks. That’s the Point

Quick Read AWSHX bars tobacco, alcohol, and gambling companies from its portfolio yet delivered a 17% one-year return and 239% gain over ten years. KO and JPM exemplify qualifying holdings, with Coca-Cola's quarterly dividend tripling since 1999 and JPMorgan trading near 15 times earnings. …

Kochav Defense (KCHV) posts $4.2M income but flags going concern risk

Korro Bio director Jean Francois Formela sells $29,916 in shares

Korro Bio director Jean Francois Formela sold 2,143 shares of the company's common stock for approximately $29,916 on August 11, 2026, under a Rule 10b5-1 trading plan. Despite recent volatility and a 67% year-to-date return, InvestingPro analysis suggests the stock may be overvalued. The …

Korro Bio (KRRO) director-affiliated funds sell 2,143 shares under 10b5-1 plan

Korro Bio director Jean Francois Formela's affiliated funds, Atlas Venture Fund XI, L.P. and Atlas Venture Opportunity Fund II, L.P., sold a total of 2,143 shares of Korro Bio common stock on August 11, 2026. These transactions, executed under a Rule 10b5-1 trading plan …

Kodiak Sciences misses Q2 estimates, shares fall 5%

Kodiak Sciences Inc. reported a wider net loss of -$1.05 per share in Q2, missing analyst estimates of -$0.98 per share, causing shares to drop over 5% in after-hours trading. The company's R&D expenses increased due to late-stage clinical programs for retinal diseases, though …

ETFs Investing in BOC Hong Kong (Holdings) Limited Stocks

Amkor (AMKR) CFO Megan Faust sells 1,000 shares via Rule 10b5-1 plan

Amkor Technology, Inc. CFO Megan Faust sold 1,000 shares of common stock at $54.45 per share on August 11, 2026, through a pre-arranged Rule 10b5-1 trading plan adopted in February 2026. Following this transaction, Faust directly holds 135,105 shares. This sale is considered neutral …

Invesco Ltd. (APC) discloses 8% ARKO Petroleum holding and key fund stake

Invesco Ltd. has disclosed an 8% beneficial ownership stake in ARKO Petroleum Corp., amounting to 1,006,708 shares of common stock. As a parent holding company, Invesco holds sole voting power over 1,006,373 shares and sole dispositive power over all 1,006,708 shares. Additionally, the Invesco …

Wellington discloses 2.52M Korn Ferry (KFY) shares held for clients

Wellington Management Group LLP and its related entities have reported a beneficial ownership of 2,519,474 shares of Korn Ferry (KFY) common stock, representing a 4.95% stake as of June 30, 2026. The shares are held for clients of various Wellington investment advisers, indicating shared …

Eikon Therapeutics Reports Second Quarter 2026 Financial Results and Provides Clinical Updates

Eikon Therapeutics reported its second-quarter 2026 financial results, highlighting significant clinical advancements across its oncology portfolio, particularly with abstracts accepted for the ESMO Congress 2026. The company detailed progress in clinical trials for its drug candidates EIK1001, EIK1003, EIK1004, and EIK1005, and announced key …

Eikon Therapeutics (EIKN) reports $171.4M first-half loss and $531M cash

Kodiak Sciences posts Q2 2026 net loss of $65.6M, cash $125.9M; DAYBREAK, PEAK readouts due Sept–Dec 2026

Kodiak Sciences reported a Q2 2026 net loss of $65.6 million and ended the quarter with $125.9 million in cash, expected to fund operations into 2027. The company reiterated upcoming Phase 3 topline readouts for DAYBREAK in September 2026 and PEAK Pivotal Analysis 1 …